Nanox Stock Rises on Software Study Findings and New Partnership

According to early findings in the ADOPT study reported in [1], Nanox.AI software improves detection of key risk factor for osteoporosis, outperforming UK National Health Service national average. This demonstrates its potential as an early screening tool [2]. In a separate announcement, Nanox entered partnership with Texas Medical Center to deploy its multi-source imaging systems [3].